Overview
What is Society For Immunotherapy Of Cancer Inc?
The Society for Immunotherapy of Cancer Inc, based in Milwaukee, Wisconsin, is a nonprofit organization dedicated to enhancing cancer patient outcomes by advancing the field of cancer immunology and immunotherapy. Through their interactions and integrations, innovations, translations, and leadership, they strive to make cancer immunotherapy a standard of care and ultimately, a reality for patients worldwide. The organization, with a significant presence, held the 37th annual meeting and pre-conference programs (SITC 2022), where experts shared cutting-edge research, fostered discussions, and provided networking opportunities. Their mission encompasses improving cancer patient outcomes and scientific advancements in immunotherapy, with a vision of transforming the concept of "cure" into a tangible reality.
Official website here: www.sitcancer.org
What are the reviews and ratings of this charity?
Charity Navigator Rating: 96% (Four-Star out of Four Stars)
The Society For Immunotherapy Of Cancer Inc has received a commendable Four-Star rating from Charity Navigator, indicating a high level of accountability and financial management. The organization's overall score is derived entirely from its strong performance in the Accountability & Finance beacon, showcasing its commitment to transparency and responsible fiscal practices.
Significantly, the charity boasts a fully independent board of directors, ensuring unbiased governance. It has implemented robust policies, including conflict of interest and whistleblower protections, further reinforcing its integrity. The financial health of the organization is reflected in its low liabilities compared to assets and a substantial percentage of its expenses directed towards programs, indicating effective use of resources.
While the organization excels in financial oversight and governance, there are no noted limitations in the available data. This positive assessment highlights the Society For Immunotherapy Of Cancer Inc as a reliable nonprofit dedicated to advancing cancer immunotherapy.
This AI summary has been generated from information found on Charity Navigator.
What do the Facebook reviews say about Society For Immunotherapy Of Cancer Inc?
100% of 10 reviewers on Facebook recommend the Society For Immunotherapy Of Cancer Inc. Here is a summary of their reviews:
Supporters express gratitude for the organization's commitment to promoting immunotherapy research, particularly in areas like kidney cancer. The positive sentiment highlights the importance of SITC's efforts in raising awareness and advancing knowledge in the field of cancer treatment.
Overall, the organization appears to effectively champion immunotherapy and engage its community, leaving a favorable impression on those who follow its initiatives.
This AI summary has been generated from reviews found on Facebook.
Is Society For Immunotherapy Of Cancer Inc legitimate?
Society For Immunotherapy Of Cancer Inc is a legitimate nonprofit organization registered as a 501(c)(3) entity. Society For Immunotherapy Of Cancer Inc submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.
Heare are some key statistics you may want to consider:
Executive Compensation: $18,000
Professional Fundraising Fees: $0
Other Salaries and Wages: $0
For more financial information, click here
Official website here: www.sitcancer.org
What is the mission statement of Society For Immunotherapy Of Cancer Inc?
The Society for Immunotherapy of Cancer Inc is dedicated to enhancing cancer patient outcomes by progressing the field of cancer immunology and immunotherapy. This organization upholds key values, including interaction and integration, innovation, translation, and leadership, to advance research and bring cancer immunotherapy closer to becoming a standard of care. The Society aims to make the prospect of a cure for cancer a reality for patients worldwide.
Official website here: www.sitcancer.org
Who is the CEO of Society For Immunotherapy Of Cancer Inc?
Leisha Emens Md Phd is the Vice President of Society For Immunotherapy Of Cancer Inc.
Official website here: www.sitcancer.org
What is the revenue of Society For Immunotherapy Of Cancer Inc?
Society For Immunotherapy Of Cancer Inc's revenue in 2022 was $17,242,766.
Official website here: www.sitcancer.org
Who are the executives of Society For Immunotherapy Of Cancer Inc and what are their salaries?
There 13 volunteers at Society For Immunotherapy Of Cancer Inc.
Here are 13 key members and their salaries:
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $5,000
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $6,500
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $2,000
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $2,000
- Related: $0
- Other: $0
- Compensation: $2,500
- Related: $0
- Other: $0
Official website here: www.sitcancer.org
Where can I find the form 990 for Society For Immunotherapy Of Cancer Inc?
Society For Immunotherapy Of Cancer Inc's most recent form 990 was submitted in 2022 and can be accessed here.
Official website here: www.sitcancer.org
Learn more at the official website: www.sitcancer.org
Mission Statement of Society For Immunotherapy Of Cancer Inc
The Society for Immunotherapy of Cancer Inc, or SITC, is a nonprofit organization dedicated to enhancing cancer patient outcomes by driving the advancement of cancer immunology and immunotherapy. With a strong focus on interaction and integration, innovation, translation, and leadership in the field, SITC strives to bring cancer immunotherapy to the forefront as a standard of care and make the word "cure" a reality for cancer patients worldwide.
In essence, SITC is committed to pushing the boundaries of scientific discovery and its practical application to revolutionize cancer treatment. Through its core values, the organization fosters collaboration and partnerships, nurtures groundbreaking research, and champions the translation of immunotherapy breakthroughs into clinical practice. By leading the way in the field, SITC remains at the helm of the fight against cancer, continually working towards a world where the promise of a cure becomes a reality for all patients.
In the pursuit of its mission, SITC brings together some of the most brilliant minds in the field of cancer research and immunotherapy, fostering a vibrant and dynamic community of scientists, clinicians, and industry professionals. With a shared vision for a future where cancer is no longer a death sentence, SITC empowers its members to collaborate and innovate, united in their quest to transform cancer care and improve the lives of countless patients.
Shop smarter and support your favorite cause with the Give Freely browser extension. Save money with coupons and donate to charity with a single click. Download now!
Impact
October, 2024
The Society for Immunotherapy of Cancer (SITC) significantly impacts cancer treatment and patient outcomes by advancing the field of cancer immunology and immunotherapy. Through its focus on interaction, innovation, translation, and leadership, SITC is committed to making immunotherapy a standard approach in cancer care. By fostering a multidisciplinary environment for education and collaboration, SITC holds annual meetings where experts share the latest research findings, facilitating both formal presentations and networking opportunities among professionals in the field.
SITC plays a vital role in integrating cutting-edge research into clinical practices, aiming not only to improve survival rates but also to enhance the quality of life for cancer patients. The organization also tracks and updates major initiatives from academia, government, and industry, ensuring that its community remains informed and engaged with the latest developments in cancer treatment. Overall, SITC's dedication to advancing immunotherapy reflects in its mission to transform cancer from a life-threatening disease into a more manageable condition, where the idea of a "cure" is increasingly viable for patients.
This information is meant to be a general summary of Society For Immunotherapy Of Cancer Inc. Please take the time to review official sources before making any decisions based upon the content provided here.
Financials
This financial information is from Propublica.
Other financial information:
This information is from the most recently submitted tax form from this organization, which was in 2022.
- Investment Income: $192,881
- Program Service Revenue: $12,615,726
- Gross Receipts: $17,739,845
Assets and Liabilities:
- Total Assets: $24,306,761
- Total Liabilities: $3,906,544
- Net Assets: $20,400,217
Want to help this charity, for free? You can click here to learn more about Give Freely
Programs
Programs are reported by nonprofits in their tax forms and are normally their tax-exempt activities.
ANNUAL MEETING
Revenue
$9,007,636
MEMBERSHIP DUES & ASSESSMENTS
Revenue
$1,490,145
PUBLISHER REVENUE
Revenue
$500,139
WORKSHOP
Revenue
$405,610
PRIMER
Revenue
$374,138
Organization Details
Founding Year
1986
Phone
(414) 271-2456Principal Officer
Leisha Emens Md Phd
Main Address
555 E WELLS STREET 1100, MILWAUKEE, WI, 53202
Website
www.sitcancer.orgNTEE Category
Code: H30 - Medical research
If you are a representative of Society For Immunotherapy Of Cancer Inc and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.